Abstract Tetrahydrobiopterin (BH 4 ) is an essential co-factor in the biosynthesis of monoamine neurotransmitters. A nano-Pt/Pd modified electrode as the electrochemical detector (ED) for high-performance liquid chromatography (HPLC) coupled with microdialysis sampling, is used to explore the effect of administration of BH 4 on the monoamine neurotransmitters in the rat striatum. The researches demonstrate that the contents of dopamine (DA), 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) increase significantly with the administration of BH 4 . The pharmaceutical kinetics is carried out to research into the time course of BH 4 effect on the concentration of monoamine neurotransmitters in rat striatum, which provides reliable data for pathology and pharmacology research on neuroscience.
BH 4 is the natural cofactor of two important amino acid hydroxylases: tyrosine h ydroxylase, the rate-limiting enzyme in the biosynthesis of dopamine from tyrosine, and tryptophan h ydroxylase, the rate-limiting enzyme in the biosynthesis of serotonin from tryptophan [1, 2] . Therefore, the deficiency of BH 4 could be responsible for the reduced biosynthesis of monoamine transmitters, and leads to some neuropsychiatric diseases such as Dopa-responsive dystonia (DRD), depression, autism and so on. The relation of BH 4 and monoamine transmitters is shown in Fig. 1 . BH 4 is also an essential cofactor of nitric oxide synthase (NOS) [3] , and plays a necessary role in the regulation of NO production, which is an important biological message in the central nervous system [4, 5] .
Therefore, alteration in BH 4 concentration may have significant physiological and pathological effects [2, 6] .
BH 4 is currently being used as a potential therapeutic agent in patients with DRD, hyperphenylalanine mia (HPA) [7] , depression [8] and Alzheimer disease [9] . So there is an increasing need for the characterization of its pharmacokinetic properties.
In the past few years, there have been many reports about the fabrication and application of alloy modified electrode. Especially Pt/Pd modified electrode has attracted much attention of the public, because of its synergistic effect on the electrocatalysis of small molecules, and its special properties such as good electrical conductivity, chemical stability. For example, Pt/Pd particles were dispersed in the polypyrrole film by electrodeposition [10] . M asatomo Yashima [11] once deposited the Pt/Pd particles on a γ-Al 2 O 3 support followed by heating in air at 600 . Pt/Pd particles were obtained by reduction of H 2 PtCl 6 or K 2 PdCl 4 in a water-in-oil microemulsion [12] . In this work, Pt/Pd particles were deposited on the glassy carbon electrode by cyclic voltammetry to o btain nano-Pt/Pd modified electrode. As an electrochemical detector for HPLC, the modified electrode successfully detected BH 4 , monoamine neurotransmitters and their metabilotes, due to its synergistic effect of alloy particles, the small size effect and surface effect of nanostructures. To the best of our knowledge, there is no report on the simultaneous determination of BH 4 , monoamine neurotransmitters and their metabolites in rat brain by using nano-Pt/Pd modified electrode. Coupled with microdialysis sampling, the method was successfully applied to the study of the effect of BH 4 administration on the neurotransmitters levels in the rat brain.
Experimental

Apparatus and reagents
Electrochemical experiments were performed with a CHI-832 electrochemical system (CHI Co., USA). The diameter of the glassy carbon electrode (Donghai Co., Japan) was 4 mm. The three-electrode system consisted of a nano-Pt/Pd modified electrode or a glassy carbon (GC) electrode as working electrode, a saturated calomel electrode (SCE) as reference electrode and a gold wire electrode as counter electrode.
Liquid chromatographic experiments were conducted on a model 510 pump and a U6K injector (Waters Assoc., USA). The injection volume was 20 µL. The column was Luna 5 µm C18 (4.6 mm × 25 cm) (Phenomenex, USA) directly attached to a C18 precolumn (15 mm × 1.0 mm). The detector consisted of a laboratory-made thin-layer cell and a CHI-832 electrochemical analyzer. All the experiments were performed at room temperature (25 ) and the pH value was calibrated with a pH meter (Horiba, Japan).
Microdialysis was accomplished by using a CMA 101 microdialysis pump (CMA Microdialysis, Stockholm, Sweden) and a CMA 12 microdialysis probe (dialysis length, 3 mm; diameter, 0.24 mm, BAS, Japan). The probe was perfused with the Ringer solution
NaHCO 3 ), at a flow rate of 1.0 µL/min.
Atomic force micrograph was obtained by using AJscanning probe microscope (Shanghai Aijian Nanoscience Development Co. Ltd., China).
(NH 4 ) 2 PdCl 4 and K 2 PtCl 6 were of analytical grade and purchased from Shanghai Chemical Reagent Co. (Shanghai, China). Tetrahydrobiopterin (BH 4 ), dopamine (DA), 5 -hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) were of analytical grade and purchased from Sigma (St. Louis, USA). All buffer components were of analytical grade or better quality. Doubly distilled deionized water was used for all solutions. for 16 cycles. After electrodeposition, nano-Pt/Pd modified electrode was rinsed with doubly distilled water and then stored in buffer solution.
Determination of monoamine neurotransmitters and its metabolites (i) In vivo microdialysis sampling. As an in vivo
sampling technique, microdialysis has been extensively used in neuroscience, pharmacology and physiology. It can prevent the interference of large molecules, mainly proteins in the biological matrix. Experiments were carried out in adult Sprague-Dawley rat (200 250 g). Eight rats were divided into two groups. The first group was anesthetized with 1.50 g· kg −1 urethane and fixed in stereotaxic frame. Then the cranial cutaneous plane was incised and underlying muscular tissues were resected to make the skull accessible. Subsequently, the orifice was made with a drill to allow the m icrodialysis probe to implant. In order to avoid cerebral compression during inserting the m icrodialysis probe, the dura was also incised. Following the above procedures, the microdialysis probe was stereotaxically implanted into the striatum at coordinates 0.2 mm posterior to the bregma, 4.0 mm lateral from midline and the middle of probe 4.5 mm below the dura [13] . Then it was perfused with Ringer solution at a flow rate of 1.0 µL· min −1 using a m icrodialysis pump. The apparatus of microdialysis referred to ref. [14] . The microdialysis samples were collected at the microdialysis rate of 1.0 µL· min
every 30 min and analyzed on the nano-Pt/Pd modified electrode. The dialysate samples collected over the first 60 min were discarded to allow recovery from the acute effects of the surgical procedure. The second group was anesthetized, sampled and analyzed in the same way. Then BH 4 solution (50 mg· kg
, 9% normal saline, 0.05% BH 4 , and 0.25% ascorbic acid) was injected at a dose of 50 mg· kg −1 body weight intraperitoneally 60 min after commencement of electrochemical detection. After administration the microdialysis sampling and analysis continued.
(ii) High performance liquid chromatography-electrochemically detection. Nano-Pt/Pd modified electrode was fixed on a laboratory-made thin-layer cell and attached to chromatography column as electrochemical d etector. Ag/AgCl electrode was used as reference electrode and the stainless steel matrix of electrolytic cell was used as counter electrode. The mobile phase was 0.2 mol· L −1 phosphate buffer solution (pH 5.0) containing 7% methanol, which was delivered at a constant flow rate of 1.0 mL· min
. All the experiments were performed at room temperature (25 ).
Results and discussion
Physical characterization of nano-Pt/Pd modified electrode
The AFM micrograph of nano-Pt/Pd modified electrode is shown in Fig. 2 . It can be found that nano-Pt/Pd alloy particles covered the whole carbon surface, and were nearly spherical in shape. The particles range in the height from 20 to 70 nm, which improved the electrocatalytic activity of nano-Pt/Pd modified electrode. 4 on GC electrode and nano-Pt/Pd modified electrode Fig. 3(a) shows the differential pulse voltammogram (DPV) of BH 4 at the bare GC electrode and the nano-Pt/Pd modified electrode in 0.2 mol· L −1 phosphate buffer solution (pH 5.0), respectively. The DPV response of BH 4 at the bare electrode exhibited a small and broad peak at +0.020 V (versus Ag/AgCl). While the oxidation current of BH 4 at the nano-Pt/Pd modified electrode increased substantially and the peak potential shifted negatively to −0.045 V (versus Ag/AgCl). Thus, a decrease of about 90mV in the over potential was obtained. This suggests that nano-Pt/Pd modified electrode shows good catalytic activity for BH 4 oxidation. The drastically enhanced catalytic response of the BH 4 is due to the synergistic effect of nano-Pt/Pd alloy particles [15] . In addition, because of the small size effect and surface effect of nanostructures, Pt-Pd nanoparticles possessed high surface area and high surface energy, which increase the catalytic active site on the surface of the modified electrode.
DPV of BH
The DPV responses of BH 4 with different concentrations at nano-Pt/Pd modified electrode are shown in Fig. 3(b) , which indicates that with the growth of BH 4 concentration, the oxidation current increased evenly. The BH 4 oxidation current had a good linear correlation with BH 4 concentration. Besides the electrochemical behavior of BH 4 , the r esponses of other monoamine neurotransmitters and their metabolites at the GC electrode and the nano-Pt/Pd modified electrode were also investigated. It was found that nano-Pt/Pd modified electrode had an effective catalysis function and could be used as the electrochemical detector for BH 4 , monoamine neurotransmitters and their metabolites in HPLC.
Liquid Chromatography conditions
(i) pH effect of mobile phase. The pH value of mobile phase has a great effect on the separation and determination of BH 4 , monoamine neurotransmitters and their metabolites in HPLC-ED. At pH<4.0, although the retention time was short, the peaks of BH 4 and DA had a little overlap. At pH>6.0, the 5-HIAA and HVA had tailed peaks and the baseline separation could not be obtained. Furthermore, the mobile phase pH had a great effect on the amperometric responses of the analytes. In consideration of BH 4 , all the monoamine n eurotransmitters and their m etabolites having good amperometric responses simultaneously, 5.0 was selected as the pH of mobile phase.
(ii) Hydrodynamic voltammetry (HDV). Hydrodynamic voltammetry is a suitable method to select the appropriate potential applied on HPLC-ED. In this study, the standard solutions of the five analytes were With the continuous increase of potential, the current response of 5-HIAA and HVA increased quickly and greatly. When the potential was greater than +0.7 V, although all the current responses underwent a slight increase, the baseline current also became high and other substances maybe responded at the electrode. In order to obtain the best selectivity and signal/noise ratio, +0.6 V was chosen as the optimum detection potential. (iii) Liquid chromatograms. Fig. 5 is the liquid chromatograms of BH 4 , DA, 5-HT, 5-HIAA and HVA at the bare GC electrode and at nano-Pt/Pd modified electrode, respectively. It was found that the current responses of the analytes at nano-Pt/Pd modified electrode were much larger than those at the bare electrode. This is attributed to the synergistic effect of Pt/Pd alloy and surface effect of Pt-Pd nanoparticles, which makes nano-Pt/Pd modified electrode exhibit good electrocatalysis in simultaneous determination of BH 4 , monoamine transmitters and their metabolites. 
Linearity, detection limits and reproducibility
To determine the linearity for the BH 4 , monoamine neurotransmitters and their m etabolites by LC-ED with nano-Pt/Pd modified electrode, a set of standard solution containing BH 4 , DA, 5-HT, 5HIAA and HVA ranging from 5×10 −10 to 5×10 −5 mol· L −1 were tested.
The linear ranges were found to be over three orders of magnitude and the correlation coefficients were larger than 0.9995. The analytical data for the five analytes are summarized in Table 1 .
The reproducibility was estimated by eight times repetitive injections of 1.0 µmol· L −1 mixture of the five analytes under the same conditions every 30 min. The relative standard deviations of the peak currents were found to be 1.5% for BH 4 , 1.1% for DA, 1.6% for 5-HT, 1.9% for 5-HIAA, and 2.2% for HVA.
In addition, the long-term stability of nano-Pt/Pd modified electrode stored at 4 in phosphate buffered saline was examined by checking its relative activity periodically. No apparent change in the current r esponses on these analytes was observed over three-week period. The results indicated that the nano-Pt/Pd modified electrode had a good stability and reproducibility when it was used as the HPLC detector Table 1 2.2% a) LC-ED conditions as in Fig. 5; b) where Y and X represent the peak current (nA) and the concentration of the analytes (µmol· L −1 ), respectively; c) the detection limits of the analytes were investigated using a signal-to-noise ratio of 3 (S/N=3).
to determine BH 4 , monoamine neurotransmitters and their metabolites.
Relative recovery of microdialysis sampling experiment
The relative recovery of a microdialysis probe is affected by the microdialysis rate. At low microdialysis rate, there will be high relative recovery. However, during the long collection time with low microdialysis rate, endogeneous compounds may be dialyzed, and BH 4 may be partly oxidized as a result of its unstability. In this work, several microdialysis rates were investigated for a proper relative recovery. In order to detect the analytes rapidly and accurately, 1.0 µL· min −1 was selected as the optimum microdialysis rate. The microdialysis relative recovery was found to be 39.6% for BH 4 , 40.7% for DA, 38.6% for 5-HT, 34.1% for 5-HIAA and 30.4% for HVA under the optimum conditions.
Pharmaceutical kinetics
(i) In vivo experiment. Fig. 6 shows the chromatograms of BH 4 , monoamine neurotransmitters and their metabolites 180 min after BH 4 administration. From the chromatograms, five analytes showed clear peak current r esponses, which suggested that nano-Pt/Pd modified electrode was very reliable and sensitive to determine BH 4 , monoamine neurotransmitters and their m etabolites in the striatum of rat brain.
(ii) Pharmaceutical kinetics analysis. Fig. 7 shows the time course of changes in BH 4 , monoamine neurotransmitters and their metabolites concentrations in rat striatum, and the effects of BH 4 on the levels of monoamine transmitters and their metabolites. BH 4 solution was injected at a dose of 50 mg·k g −1 body weight intraperitoneally 60 min after commencement of dialysate-collection. Following BH 4 administration, the concentration of BH 4 increased sharply and reached a peak within 30 min. Then the content of BH 4 decreased gradually and the decline slowed down. The change of DA was similar to those of BH 4 . The concentration of DA reached the highest value within 30 min after injection, and then descended slowly. But even at the end of microdialysis, DA still had a 2-fold concentration compared with the control group. The experimental results demonstrate that the concentration of DA increased with the rise of the concentration of BH 4 [16, 17] . After BH 4 administration, the concentration of 5-HT also increased rapidly and reached the maximum 30 min after injection. The concentration of 5-HT in the striatum increased about 70% compared with the control group. This is because that intraperitoneally administered BH 4 could pass the blood-brain barrier, and improved the activity of tyrosine h ydroxylase and tryptophan hydroxylase, which accelerated the biosynthesis of DA and 5-HT and increased the content of monoamine neurotransmitters in rat striatum.
From Fig. 7 it can be seen that there was also an increase in the concentration of the m etabolites, HVA and 5-HIAA. The metabolites were observed to have the similar change in the concentration of DA and 5-HT [3, 18] . All the results suggest that exogenous BH 4 could enhance the concentration of monoamines and their metabolites in the striatum of rat brain, and thus improved the symptoms of DRD. Further studies are proceeding now in our laboratory.
Conclusions
In this paper, nano-Pt/Pd modified electrode was prepared and used as the amperometric detector for liquid chromatography. The application of this method coupled with microdialysis sampling for in vivo simultaneous determination of BH 4 , monoamine neurotransmitters and their metabolites in rat striatum was satisfactory. The effect of BH 4 on monoamine neurotransmitters and their metabolites in the striatum of rat brain was investigated, which provided reliable data for the pathology and pharmacology research on DRD and provided effective analytical method for the screening of new therapeutic medicine.
